At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Exparel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.
In Brief
A Phase 4 clinical trial evaluating Exparel and TAP Block for Postoperative Pain. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedOct 2014
Primary CompletionNov 2014
TodayJul 2026
First PostedOct 15, 2014
Enrollment StartJul 1, 2013
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.7 years ago
Interventions
Expareldrug
In this arm as described above the intervention will be TAP block injection under ultrasound guidance using Exparel.
TAP Blockprocedure
no intervention will be done to this arm.